Actelion relishes HY bid in Swissies
Actelion, the speculative grade rated Swiss pharmaceutical company, has issued Sfr210m (€170m) of senior unsecured 2015 bonds with a 4.875% coupon in a domestic issue on Tuesday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts